Related Experiment Video

Updated: Aug 6, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Treatment of hyperlipidemia in HIV-infected patients

S M Geletko1, A R ZuWallack

  • 1College of Pharmacy, University of Rhode Island (URI), Providence, RI USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|April 12, 2001
PubMed

Insights

Treating hyperlipidemia in HIV patients requires careful consideration of antiretroviral therapy side effects. Standard National Cholesterol Education Program (NCEP) guidelines may need adjustments for this population.

Area of Science:

  • Internal Medicine
  • Infectious Diseases
  • Cardiology

Background:

  • Hyperlipidemia is a frequent complication in patients with human immunodeficiency virus (HIV) undergoing antiretroviral therapy (ART).
  • Specific ART drugs, such as protease inhibitors and stavudine, are strongly associated with elevated lipid levels.
  • The unique metabolic profile and polypharmacy in HIV patients may alter lipid metabolism and response to treatment.

Purpose of the Study:

  • To discuss the complexities of managing hyperlipidemia in HIV-infected patients.
  • To highlight the limitations of existing National Cholesterol Education Program (NCEP) guidelines for this population.
  • To outline potential treatment strategies and considerations.

Main Methods:

  • Review of current literature on hyperlipidemia in HIV.
  • Analysis of the impact of antiretroviral drugs on lipid profiles.
  • Assessment of NCEP guidelines' applicability to HIV patients.
  • Discussion of pharmacologic and non-pharmacologic treatment options.

Main Results:

  • HIV-related hyperlipidemia may be refractory to standard treatments due to underlying pathogenetic mechanisms.
  • Drug-food interactions and cytochrome P-450 metabolism complicate pharmacotherapy.
  • Non-pharmacologic interventions like diet and exercise are important but may be challenging to implement.
  • Drug therapy (niacin, statins, fibric acid derivatives, probucol) is indicated for specific lipid profiles and cardiac risk.

Conclusions:

  • Hyperlipidemia management in HIV patients necessitates a tailored approach, considering ART interactions and patient-specific factors.
  • Close monitoring of lipid levels, potentially more frequent than standard NCEP recommendations, is crucial.
  • Switching ART regimens should be approached cautiously due to the risk of viral rebound and disease progression.

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...